Shamrock Asset Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Shamrock Asset Management's GILD Position: Q3 2019 in Review
Shamrock Asset Management reduced its Gilead Sciences (GILD) stake by 4.7% in Q3 2019, selling an estimated $22.2K and leaving 6,815 shares worth $432K. The position accounts for 0.34% of the portfolio, ranked #68.
Shamrock Asset Management first reported a position in GILD in Q1 2014 and has held it in 21 quarters since. The position peaked at $587K in Q3 2017. 1,462 funds tracked by Wall St. Rank hold GILD as of Q3 2019.
- Shamrock Asset Management held 6,815 shares of Gilead Sciences worth $432K as of Q3 2019.
- Shamrock Asset Management sold 339 Gilead Sciences shares in Q3 2019, an estimated $22.2K.
- Gilead Sciences made up 0.34% of Shamrock Asset Management's portfolio in Q3 2019, its #68 holding.
- Shamrock Asset Management first reported a position in Gilead Sciences in Q1 2014 and has held it in 21 quarters since.
- Shamrock Asset Management's Gilead Sciences position peaked at $587K in Q3 2017.
- 1,462 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2019.
Based on Shamrock Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.